Valbiotis Obtains Patent for Its Active Substance TOTUM•63 in China, a Large Potential Market for the Prevention of Type 2 Diabetes and Metabolic Diseases
The China National Intellectual Property Administration (CNIPA) has granted comprehensive protection for the composition and…